{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T20:04:51Z","timestamp":1767470691056,"version":"3.48.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CSL Vifor"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04655-6","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T09:18:15Z","timestamp":1764148695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic kidney disease associated pruritus and healthcare resource utilization in European hemodialysis patients: results from an electronic patient-reported outcome survey"],"prefix":"10.1186","volume":"27","author":[{"given":"James","family":"Fotheringham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Pisoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sammantha","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilo","family":"Schaufler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Ruessmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Karaboyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"5","key":"4655_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2215\/CJN.09600818","volume":"14","author":"N Sukul","year":"2019","unstructured":"Sukul N, Speyer E, Tu C, Bieber BA, Li Y, Lopes AA, et al. Pruritus and patient reported outcomes in non-dialysis CKD. Clin J Am Soc Nephrol. 2019;14(5):673\u201381.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4655_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.xkme.2020.08.011","volume":"3","author":"N Sukul","year":"2021","unstructured":"Sukul N, Karaboyas A, Csomor PA, Schaufler T, Wen W, Menzaghi F, et al. Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients. Kidney Med. 2021;3(1):42\u2013e531.","journal-title":"Kidney Med"},{"issue":"12","key":"4655_CR3","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/ndt\/gfl461","volume":"21","author":"RL Pisoni","year":"2006","unstructured":"Pisoni RL, Wikstr\u00f6m B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: international results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495\u2013505.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"12","key":"4655_CR4","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.2215\/CJN.03280317","volume":"12","author":"HC Rayner","year":"2017","unstructured":"Rayner HC, Larkina M, Wang M, Graham-Brown M, van der Veer SN, Ecder T, et al. International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017;12(12):2000\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"4655_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1053\/j.ajkd.2023.04.008","volume":"82","author":"N Sukul","year":"2023","unstructured":"Sukul N, Zhao J, Pisoni RL, Walpen S, Schaufler T, Asgari E, et al. Pruritus in hemodialysis patients: longitudinal associations with clinical and patient-reported outcomes. Am J Kidney Dis. 2023;82(6):666\u201376.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4655_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40271-023-00668-1","volume":"17","author":"J Fotheringham","year":"2024","unstructured":"Fotheringham J, Guest J, Latus J, Lerma E, Morin I, Schaufler T, et al. Impact of difelikefalin on the health-related quality of life of haemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus: a single-arm intervention trial. Patient. 2024;17(2):203\u201313.","journal-title":"Patient"},{"issue":"7","key":"4655_CR7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/ndt\/gfad245","volume":"39","author":"DE Weiner","year":"2023","unstructured":"Weiner DE, Schaufler T, McCafferty K, Kalantar-Zadeh K, Germain M, Ruessmann D, et al. Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis. Nephrol Dial Transplant. 2023;39(7):1125\u201337.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"1","key":"4655_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ckj\/sfac187","volume":"16","author":"R Agarwal","year":"2023","unstructured":"Agarwal R, Burton J, Gallieni M, Kalantar-Zadeh K, Mayer G, Pollock C, et al. Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus. Clin Kidney J. 2023;16(1):30\u201340.","journal-title":"Clin Kidney J"},{"issue":"3","key":"4655_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1912770","volume":"382","author":"S Fishbane","year":"2020","unstructured":"Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F. A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med. 2020;382(3):222\u201332.","journal-title":"N Engl J Med"},{"issue":"5 Suppl 2","key":"4655_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0272-6386(04)01099-6","volume":"44","author":"RL Pisoni","year":"2004","unstructured":"Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA. The dialysis outcomes and practice patterns study (DOPPS): design, data elements, and methodology. Am J Kidney Dis. 2004;44(5 Suppl 2):7\u201315.","journal-title":"Am J Kidney Dis"},{"key":"4655_CR11","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1046\/j.1523-1755.2000.07413.x","volume":"57","author":"EW Young","year":"2000","unstructured":"Young EW, Goodkin DA, Mapes DL, Port FK, Keen ML, Chen K, et al. The dialysis outcomes and practice patterns study (DOPPS): an international hemodialysis study. Kidney Int. 2000;57:S74\u201381.","journal-title":"Kidney Int"},{"issue":"10","key":"4655_CR12","doi-asserted-by":"publisher","first-page":"sfae276","DOI":"10.1093\/ckj\/sfae276","volume":"17","author":"M Guedes","year":"2024","unstructured":"Guedes M, Tu C, Sukul N, Asgari E, Guebre-Egziabher F, Ruessmann D, et al. Chronic kidney disease-associated pruritus: a comparison of instruments and associations with patient-reported outcomes using an electronic patient-reported outcome survey in Europe. Clin Kidney J. 2024;17(10):sfae276.","journal-title":"Clin Kidney J"},{"key":"4655_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00451725","volume":"3","author":"RD Hays","year":"1994","unstructured":"Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL TM) instrument. Qual Life Res. 1994;3:329\u201338.","journal-title":"Qual Life Res"},{"issue":"12","key":"4655_CR14","first-page":"Cd011393","volume":"12","author":"D Hercz","year":"2020","unstructured":"Hercz D, Jiang SH, Webster AC. Interventions for itch in people with advanced chronic kidney disease. Cochrane Database Syst Rev. 2020;12(12):Cd011393.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"4655_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.semnephrol.2015.06.009","volume":"35","author":"SA Combs","year":"2015","unstructured":"Combs SA, Teixeira JP, Germain MJ. Pruritus in kidney disease. Semin Nephrol. 2015;35(4):383\u201391.","journal-title":"Semin Nephrol"},{"issue":"2","key":"4655_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1525-139X.2005.18209.x","volume":"18","author":"PL Kimmel","year":"2005","unstructured":"Kimmel PL, Peterson RA. Psychosocial factors in patients with chronic kidney disease: depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs. Semin Dial. 2005;18(2):91\u20137.","journal-title":"Semin Dial"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04655-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04655-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04655-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T20:02:02Z","timestamp":1767470522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04655-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4655"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04655-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained for the ePRO ancillary study conducted within DOPPS phase 7 (2021\u20132023), in accordance with the Declaration of Helsinki and relevant local regulations. All participants provided additional informed consent prior to enrollment and completion of quarterly questionnaires.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JF has received research funding from CSL-Vifor, AstraZeneca and Boehinger-Ingelheim, in addition to funding from the National Institute of Health Research into outcomes for people on dialysis.CT, RP, SF, and AK are employees of Arbor Research Collaborative for Health, which administers the DOPPS. All funds are made to Arbor Research Collaborative for Health and not directly to the authors.RPF reports: Honoraria (paid to employer) from Astra Zeneca, Boehringer-Lilly, Akebia, Bayer, GSK, Novo Nordisk for participation in Advisory Boards and educational activities. Consulting fees Scientific Leadership in clinical trials from the George Clinical. Research grants from Fresenius Medical Care, National Council for Scientific and Technological Development. RPF is employed by Arbor Research Collaborative for health, who runs the DOPPS studies. Global support for the ongoing DOPPS Programs is provided without restriction on publications by a variety of funders. Funding is provided to Arbor Research Collaborative for Health and not to RPF. For details see https:\/\/www.dopps.org\/AboutUs\/Support.aspx. DR is an employee of CSL Vifor, and TS was an employee of CSL Vifor at the time the manuscript was developed.MV has received research support from Fresenius Medical Care, CSL Vifor, Admesy, Calciscon AG, Astra-Zeneca, Dutch Kidney Foundation, Dutch Ministry of Economics (Health Holland) (all to institution); participated in advisory boards for Astra-Zeneca, Boehringer Ingolheim, Kyowa Kirin, CSL Vifor (fees all to institution); and participated in committees: KDIGO executive committee; KDIGO subcommittee on CKD-MBD, Advisory board Dutch ministry of health (all unpaid).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}